TOPBP1
Basic information
Region (hg38): 3:133598175-133662380
Links
Phenotypes
GenCC
Source:
- pulmonary arterial hypertension (No Known Disease Relationship), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOPBP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 117 | 126 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 117 | 8 | 1 |
Variants in TOPBP1
This is a list of pathogenic ClinVar variants found in the TOPBP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-133601269-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
3-133601277-A-T | not specified | Uncertain significance (Dec 03, 2021) | ||
3-133601285-C-G | not specified | Uncertain significance (Dec 03, 2021) | ||
3-133601320-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
3-133601342-T-A | not specified | Uncertain significance (Jun 24, 2022) | ||
3-133601359-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
3-133601366-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
3-133608560-T-A | not specified | Uncertain significance (May 17, 2023) | ||
3-133608563-G-T | not specified | Uncertain significance (Jul 26, 2021) | ||
3-133608575-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
3-133608588-C-A | TOPBP1-related disorder | Benign (Mar 20, 2019) | ||
3-133608613-T-C | TOPBP1-related disorder | Benign (Oct 21, 2019) | ||
3-133608620-T-C | not specified | Uncertain significance (Sep 20, 2024) | ||
3-133608899-G-A | not specified | Uncertain significance (Nov 20, 2024) | ||
3-133608925-T-G | not specified | Uncertain significance (Mar 15, 2024) | ||
3-133611025-T-G | not specified | Uncertain significance (Nov 09, 2023) | ||
3-133611067-T-G | TOPBP1-related disorder | Likely benign (Sep 03, 2020) | ||
3-133611076-T-C | TOPBP1-related disorder | Likely benign (Mar 01, 2019) | ||
3-133611079-C-A | not specified | Uncertain significance (Nov 11, 2024) | ||
3-133611120-T-A | not specified | Uncertain significance (Jan 23, 2023) | ||
3-133612386-C-T | TOPBP1-related disorder | Benign (Oct 21, 2019) | ||
3-133612394-C-T | not specified | Uncertain significance (Dec 10, 2024) | ||
3-133612417-G-C | Uncertain significance (Jul 07, 2021) | |||
3-133612432-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
3-133616846-C-T | not specified | Uncertain significance (Jul 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TOPBP1 | protein_coding | protein_coding | ENST00000260810 | 27 | 63719 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 6.95e-11 | 124643 | 0 | 9 | 124652 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.97 | 610 | 763 | 0.799 | 0.0000389 | 9976 |
Missense in Polyphen | 122 | 197.54 | 0.61758 | 2508 | ||
Synonymous | -0.455 | 276 | 267 | 1.04 | 0.0000140 | 2843 |
Loss of Function | 7.70 | 2 | 72.9 | 0.0274 | 0.00000384 | 953 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000973 | 0.0000973 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000556 |
Finnish | 0.000143 | 0.000139 |
European (Non-Finnish) | 0.0000278 | 0.0000265 |
Middle Eastern | 0.0000557 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for DNA replication. Plays a role in the rescue of stalled replication forks and checkpoint control. Binds double- stranded DNA breaks and nicks as well as single-stranded DNA. Recruits the SWI/SNF chromatin remodeling complex to E2F1- responsive promoters. Down-regulates E2F1 activity and inhibits E2F1-dependent apoptosis during G1/S transition and after DNA damage. Induces a large increase in the kinase activity of ATR (PubMed:16530042). {ECO:0000269|PubMed:10498869, ECO:0000269|PubMed:11395493, ECO:0000269|PubMed:11714696, ECO:0000269|PubMed:12697828, ECO:0000269|PubMed:15075294, ECO:0000269|PubMed:16530042}.;
- Pathway
- Homologous recombination - Homo sapiens (human);ATR Signaling;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;Gene expression (Transcription);DNA Double-Strand Break Repair;Generic Transcription Pathway;Homology Directed Repair;RNA Polymerase II Transcription;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;Fanconi anemia pathway;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Cell Cycle;BARD1 signaling events;Processing of DNA double-strand break ends;ATR signaling pathway;E2F transcription factor network;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.182
Intolerance Scores
- loftool
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.29
Haploinsufficiency Scores
- pHI
- 0.517
- hipred
- Y
- hipred_score
- 0.826
- ghis
- 0.668
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.673
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Topbp1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Zebrafish Information Network
- Gene name
- topbp1
- Affected structure
- hematopoietic stem cell homeostasis
- Phenotype tag
- abnormal
- Phenotype quality
- decreased process quality
Gene ontology
- Biological process
- DNA metabolic process;DNA repair;cellular response to DNA damage stimulus;response to ionizing radiation;mitotic DNA replication checkpoint
- Cellular component
- condensed nuclear chromosome;spindle pole;male germ cell nucleus;nucleus;nucleoplasm;chromosome;cytoplasm;microtubule organizing center;actin cytoskeleton;nuclear body;PML body
- Molecular function
- DNA binding;protein binding;protein C-terminus binding;identical protein binding